Experimental drug targets prostate cancer's chief weakness
from Medical News Today
A significant number of men in the United States and across the world face a diagnosis of prostate cancer, and in some cases, recurring tumors are so resilient that they do not respond to treatment. New research may have found out why, and potentially how to destroy these stubborn tumors.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063